CSPC Pharmaceutical Group Limited (CVG) — Capital Reinvestment Ratio
CSPC Pharmaceutical Group Limited (CVG) has a Capital Reinvestment Ratio of 0.12x as of September 2020, meaning it reinvests 0% of its operating cash flow (€2.16 Billion) in capital expenditures (€258.14 Million). See cash generation quality of CSPC Pharmaceutical Group Limited to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
CSPC Pharmaceutical Group Limited Capital Reinvestment Ratio (2013–2025)
This chart tracks CSPC Pharmaceutical Group Limited's Capital Reinvestment Ratio across 13 annual periods.
Annual Capital Reinvestment Ratio for CSPC Pharmaceutical Group Limited (2013–2025)
Year-by-year Capital Reinvestment Ratio for CSPC Pharmaceutical Group Limited from 2013 to 2025. For live market cap and broader valuation context, see CVG market cap overview.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.39x | €5.83 Billion | €2.28 Billion | ▼ -33.8% |
| 2024 | 0.59x | €4.53 Billion | €2.68 Billion | ▲ +30.4% |
| 2023 | 0.45x | €4.18 Billion | €1.89 Billion | ▲ +55.6% |
| 2022 | 0.29x | €7.63 Billion | €2.22 Billion | ▼ -4.3% |
| 2021 | 0.30x | €4.64 Billion | €1.41 Billion | ▲ +51.1% |
| 2020 | 0.20x | €6.74 Billion | €1.36 Billion | ▼ -59.6% |
| 2019 | 0.50x | €3.78 Billion | €1.88 Billion | ▲ +13.3% |
| 2018 | 0.44x | €3.80 Billion | €1.67 Billion | ▲ +22.6% |
| 2017 | 0.36x | €3.29 Billion | €1.18 Billion | ▼ -1.7% |
| 2016 | 0.36x | €2.92 Billion | €1.06 Billion | ▲ +0.4% |
| 2015 | 0.36x | €2.25 Billion | €815.69 Million | ▼ -18.8% |
| 2014 | 0.45x | €1.81 Billion | €807.00 Million | ▼ -39.0% |
| 2013 | 0.73x | €814.86 Million | €597.12 Million | — |